Title: Why are most phospholipidosis inducers also hERG blockers?
Journal: Archives of toxicology 20171201
129-77-1
23182-46-9
76-90-4
62869-69-6
3485-62-9
856860-16-7 | 1,5-Dimethyl-1h-pyrazole-4-carbonitrile | AA00G2OP | MFCD04969708
84762-69-6 | 4-Chloro-6-morpholinopyrimidin-5-amine | AA00G2XN | MFCD00473322
850411-14-2 | 4-(3-Ethoxycarbonylpiperidine)carboxamidophenylboronic acid, pinacol ester | AA00G33P | MFCD06657751
84250-73-7 | 4-Bromo-N-methylaniline, HCl | AA00G3C9 | MFCD08456851
758683-21-5 | Bay 65-1942 (R forM) | AA00G3KT | MFCD22666587
749896-75-1 | 2-(4-(3,4-Dichlorophenylsulfonamido)phenyl)acetic acid | AA00G3Q3 | MFCD06335572
84227-69-0 | {3-[(diethylaMino)Methyl]phenyl}MethanaMine | AA00G3TZ | MFCD08444591
80120-03-2 | 4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE | AA00G415 | MFCD02178907
77479-49-3 | 3-Ethylisoxazol-5-amine | AA00G4B9 | MFCD10695638
849021-12-1 | 2-Dimethylaminobenzylhydrazine diHCl | AA00G4IX | MFCD06245511
